We are now accepting nominations and applications as part of the 2019 selection cycle for new members for several our advisory panels. Applications are due by midnight ET on March 29.
2019 Selection Cycle Openings: We are seeking members for the Patient Engagement, Healthcare Delivery and Disparities Research, Rare Disease, and Clinical Trials panels. In addition, the Advisory Panel on Clinical Effectiveness and Decision Science is seeking a new member from the payer community.
Before you submit an application, we invite you to:
Requirements and Expectations
Panelists are required to abide by PCORI’s Conflict of Interest Policy and complete and submit a PCORI Conflict of Interest Disclosure Form for Advisory Panel Members [ PDF | Word ]. Panelists are also required to attend two to four in-person meetings in the DC area and several remote access meetings throughout the year, and to read background materials in preparation for all meetings. PCORI will make public panelists’ Conflict of Interest Disclosures, affiliations, and the stakeholder communities they represent as reported to us.
How to Submit a Third-Party Nomination
PCORI accepts third-party nominations for its advisory panels. To make a nomination, an individual or organization should send a nomination letter to [email protected]. Before making a nomination, we encourage nominators to review our application fields for guidance on presenting as robust a portrait of the nominee(s) as possible.
Following nomination, all nominees must complete their own application. Please be sure to notify the individual of their nomination as PCORI does not do so. Should PCORI need additional information from the nominee, we will contact the nominee directly.
PCORI reviews all applications and nominations with an eye toward developing balanced, inclusive panels.
Application Review and Selection Process
Applications will continue to be reviewed for selection on a rolling basis. PCORI’s executive staff establishes multidisciplinary Advisory Panel Applicant Review Teams for each panel. To mitigate potential conflicts of interest, review team members are required to recuse themselves from initial evaluations of any applicants with whom they had a close professional or personal association. Selection criteria are used to evaluate each applicant’s experience and ability to contribute to each panel’s specific scope of work. In the interest of consistency, applicants are reviewed within the context of other applicants from their stakeholder group. Learn more about our review and selection process.
How to Apply
Please click the "APPLY HERE" button below to create an application and fill in all mandatory fields. You can save your application at any time by clicking 'Save' and return to it at a later date. We encourage applicants to review our application fields prior to starting the application. PCORI accepts letters of support from individuals or organizations. The application portal will not allow attachment uploads, so letters can be sent to [email protected] once an application is submitted.
Our online application form will take approximately 30 minutes to complete. It includes a series of multiple-choice and open-form questions. Applicants must provide a personal statement (250 to 500 words) that clearly describes their background, experience, degree to which expertise and background could improve our work, and reasons for applying.
Applicants have the option to provide supporting documents (resume/curriculum vitae/list of relevant experience) by copying and pasting them into text boxes. Incomplete applications will not be reviewed or considered. Applicants have the option to indicate if they wish to be considered for up to two panels and will be prompted to rank selected panels in order of preference. This ranking will be used in the event two or more Advisory Panel Applicant Review Teams would like to select the same applicant.
For information on how to complete the Advisory Panel Application, please reference the Advisory Panel Applicant Portal Guide.
Posted: December 5, 2013; Updated: February 8, 2019